Practical considerations for estimating clinical trial accrual periods: application to a multi-center effectiveness study by Carter, Rickey E et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Medical Research 
Methodology
Open Access Research article
Practical considerations for estimating clinical trial accrual periods: 
application to a multi-center effectiveness study
Rickey E Carter*1,  S u s a nCS o n n e 2 and Kathleen T Brady2
Address: 1Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA and 
2Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA
Email: Rickey E Carter* - carterre@musc.edu; Susan C Sonne - sonnesc@musc.edu; Kathleen T Brady - bradyk@musc.edu
* Corresponding author    
Abstract
Background: Adequate participant recruitment is vital to the conduct of a clinical trial. Projected
recruitment rates are often over-estimated, and the time to recruit the target population (accrual
period) is often under-estimated.
Methods: This report illustrates three approaches to estimating the accrual period and applies the
methods to a multi-center, randomized, placebo controlled trial undergoing development.
Results: Incorporating known sources of accrual variation can yield a more justified estimate of
the accrual period. Simulation studies can be incorporated into a clinical trial's planning phase to
provide estimates for key accrual summaries including the mean and standard deviation of the
accrual period.
Conclusion: The accrual period of a clinical trial should be carefully considered, and the allocation
of sufficient time for participant recruitment is a fundamental aspect of planning a clinical trial.
Background
Clinical trials often plan to enroll hundreds to thousands
of human subjects, and careful and regulated planning is
employed to ensure that the trial's scientific objectives are
fulfilled. However, the importance of the feasibility and
timeliness of participant accrual is often minimized dur-
ing the planning stage. This is unfortunate since the
recruitment of human subjects into a clinical trial must be
timely and is vital to the success of the trial [1,2]. In addi-
tion, a slowly progressing trial may expose the human
subjects to ineffective treatments for a longer period of
time than necessary, and as such, human subject protec-
tion may be compromised [2,3]. Therefore, a clinical trial
must be planned with an adequate understanding of the
potential accrual rate so that the clinical trial's scientific
objectives can be evaluated in a timely manner.
The first step in estimating the clinical trial's accrual
period is to estimate the accrual rate. In the context of a
multi-center trial, each clinical center's rate will need to be
estimated. One approach for evaluating each clinical
center is to solicit information via a questionnaire. Con-
tent of the questionnaire could include measurements of
the total number of cases currently or recently seen for the
targeted condition, a listing of other clinical trials that
might compete for the same patients, and a summary of
the investigator's (or clinical center's) experience meeting
prior accrual expectations. The completed questionnaires
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can be used to formulate an initial estimate of the accrual
rate for each participating clinical center.
However, experience has shown the accrual period is
longer than planned even when such tangible efforts are
made to estimate the accrual rate. Carter [1] presented a
methodological examination of this issue and developed
a statistical model to estimate the accrual period of a clin-
ical trial. It was argued that utilizing only the historical
mean for the projected accrual period fails to account for
the variation in the rate that may occur as the study
progresses. In this brief report, we illustrate three
approaches to estimating the accrual period of a clinical
trial and offer discussion on potential best practices.
Methods
Unconditional approach
A common approach to estimating the accrual period in a
clinical trial is to divide the sample size by the expected
rate. Often, the expected rate for the clinical trial is esti-
mated by summing the historical trends at each participat-
ing research site to create a study-wide estimate of the
accrual rate. For example, if subjects are to be recruited
from 5 sites at the expected rate of 5 participants per
month per site, then one could estimate that it would take
8 months to enroll 200 participants using the combined
rate of 25 participants per month. However, since the rate
of 25 participants per month is assumed to be fixed in
value, it is best to consider that "on average" it may take 8
months to enroll 200 participants. The obvious limitation
of this approach is that there is no mechanism to account
for known sources of variation in the rate. For example, if
the 5 sites were to begin enrolling at different times, then
a study-wide estimate of 25 participants per month is no
longer tenable. The following approach directly addresses
this limitation.
Conditional rates
A more accurate estimate of the accrual period is possible
when additional prior information is incorporated into
the model. Two important sources of variation in the
overall accrual period are the rates at which individual
sites accrue and the length of time in which sites actively
recruit participants. For example, suppose that a large
research institution (Site A) may be capable of recruiting
15 participants per month and that four additional sites
are only capable of recruiting a combined 10 participants
per month. Then, the point in time in which the Site A
begins enrollment will greatly affect the trial's overall
accrual rate. Moreover, the timing of Site A's initiation and
subsequent accrual should be critically evaluated by the
sponsor.
For example, if it is known in advance that Site A will take
4 to 8 weeks longer to initiate recruitment than the other
four sites, an estimate of 8 months to enroll 200 partici-
pants would seem overly optimistic. The sponsor might
be interested in determining the effect of including Site A
on key trial markers (e.g., feasibility, cost, and total clini-
cal trial duration) by allowing for up to an 8-week delay
in Site A's initiation. However, the calculation of a more
refined accrual period, which would drive many of the
cost estimates, would require the adjustment for time
dependent changes in the overall accrual rate. Fortunately,
computational tools such as a spreadsheet aid in the nec-
essary calculations.
Poisson process
The methodology presented by Carter [1] allows for a
more sophisticated model that can incorporate a variety
of sources of variations. In this paper, the exploration of
mean accrual time will be examined. As the two previous
approaches illustrate, the mean number of participants
per month per site was assumed to be fixed, yet the overall
accrual time varied. The source of variation introduced
was a delay in the initiation of the protocol at a site. There
is another source of variation. Just as is well established in
economics, historical trends may not adequately reflect
future trends especially when short periods of time are
considered.
One approach to incorporating variation into mean
number of participants per month is to assume that par-
ticipants arrive into the study according to a known prob-
ability distribution. Carter [1] proposed the Poisson
distribution since it has widespread applications that
often include the statistical modeling of the number of
arrivals or observations [4,5]. Essentially, this method
simulates the accrual into a trial using a random number
generator. At the end of each simulation iteration, the
number of days (or months) required for the program to
reach the sample size is recorded. When the simulations
are repeated many times, an empirical distribution of the
accrual period is obtained. Using this empirical distribu-
tion, one can answer questions related to the probability
of completing accrual within a specified time as well as
observe how much variance in accrual time can be
expected given the model assumptions. This probabilistic
approach is most beneficial when a finite amount of time
has been granted for the clinical trial. Thus by condition-
ing on the predetermined time, one could estimate the
number of clinical centers and the rate per month needed
to ensure with high probability, such as 80%, that the
clinical trial will complete enrollment before the allocated
time expires.
Results
To illustrate these three approaches, a multi-center proto-
col undergoing development is presented. The primary
objective of the study is to measure the effectiveness of aBMC Medical Research Methodology 2005, 5:11 http://www.biomedcentral.com/1471-2288/5/11
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selective serotonin reuptake inhibitor (SSRI) in the treat-
ment of depression in a patient population with comor-
bid substance dependence. A sample size of 360
participants, enrolled from 10–12 research sites, has been
estimated to test the primary hypothesis with 90% power.
While the protocol is still being finalized, an initial esti-
mate of the accrual period is of practical interest to the
protocol investigators.
The final selection of the research sites has not been made,
but to be considered for the trial, each site must demon-
strate a patient population that would support enrolling
two participants per month in the trial. In addition, it is
anticipated that the protocol will be rolled out initially at
one to two sites with the remaining sites coming online
three to eight months later. Table 1 presents the results of
the presented models as well as a variation of the Poisson
process model that allows for fluctuations in assumed
accrual rate over time. For simplicity, each site's accrual
rate is assumed to equal two participants per month and
ten sites (instead of up to 12) have been chosen so that a
conservative estimate of the accrual period is obtained.
Using these assumptions and the unconditional
approach, it is estimated that 18 months would be
required (360 / (2 * 10)) to accrue the participants. How-
ever, this calculation does not account for the delayed
start of the majority of the sites.
To account for the delay, the conditional model could be
utilized. Suppose the initial rate of accrual is two partici-
pants per month for the first two months while the proto-
col is active at only one site. At the start of month three,
one additional site will be released for enrollment to bring
the estimated accrual rate to four participants per month.
Figure 1 illustrates the expected accrual as additional sites
are added to the study and that full accrual potential is not
reached until approximately 1/3 of the trial duration has
passed. The estimate of 23 months seems much more rea-
sonable given the staggered initiation process; however,
additional models could be implemented to examine the
effects of fluctuations in the accrual rates. Two separate
Poisson models are presented in Table 1. Both models use
the initiation pattern of the conditional model; however,
the daily rate, which is the monthly rate divided by the
standard number of days in the month, has been adjusted
to reflect anticipated enrollment dynamics. Specifically,
while the clinical sites treat potential participants every
day of the week, research staff are expected to be available
only five days per week. Thus, the estimated rate per
month is discounted effectively by 5/7 to reflect this antic-
ipated pattern. The second Poisson model further adjusts
the estimate of 2 participants per month downward to be
uniformly distributed between zero and two. Such an
adjustment might be necessary to account for the differ-
ence in the number of participants eligible for the trial and
the number that will actually consent to participate in the
research. In addition, this reduction in the overall rate also
adjusts the rate downward for other competing demands
that could affect the participant accrual rate but would be
difficult to quantify directly. As Table 1 illustrates, a dra-
matic difference in the expected accrual period is obtained
if the rate is allowed to fluctuate uniformly on the interval
0 to 2; however, the conditional approach and the fixed-
rate Poisson model provide similar results with the excep-
tion that the Poisson-based approach provides additional
summary statistics that may be of interest during the plan-
ning phase.
Discussion
The estimation of the accrual period of a clinical trial has
dramatic practical, scientific and economic consequences
and warrants greater attention in practice. As our example
illustrates, the unconditional approach, while simple to
implement, can yield results not consistent with trial
assumptions, and may endanger the successful
completion of the trial. It is acknowledged that the most
Table 1: Estimated accrual periods for a 360-participant, 10-center clinical trial.
Unconditional Approacha Conditional Ratesb Poisson Processc,d Poisson Process Variable 
Ratesc,e
Estimated Accrual Period
(in months)
Mean 18 23 23.2 42.6
Standard Deviation NA NA 1.0 8.0
Range NA NA [20.1, 25.8] [28.0, 84.0]
75th Percentile NA NA 24.0 46.0
a10 sites enrolling at a rate of 2 participants per month.
bFor the conditional rate, the rate per month is illustrated in Figure 1.
cBased on 500 simulation iterations
dA rate of 2 participants per month with recruitment on 5 days a week
eA rate uniformly distributed on [0,2] with recruitment on 5 days a weekBMC Medical Research Methodology 2005, 5:11 http://www.biomedcentral.com/1471-2288/5/11
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complicated aspect pertaining to the estimation of accrual
periods is the determination of the expected rate. As our
example illustrates, sometimes dramatically different
results occur with what are apparently minor modifica-
tions to model assumptions. When the potential impact
of a poorly accruing clinical trial is considered, spending
additional time examining the effects of model assump-
tions is well justified. In the end, accounting for variation
and planning are essential components of good clinical
research.
For the research study under consideration in this exam-
ple, an estimate of 24 months to complete study recruit-
ment seems reasonable. An accrual rate of at least two
participants per month is the minimum requirement, so
the expected rate after adjustment for screening to enroll-
ment dropout percentages should still yield an accrual
rate of approximately two per month. However, a more
refined estimate of the accrual period can be obtained
once final selection of the research sites has been made
and all historical information has been analyzed. These
models can also be applied after study enrollment has
begun, and in the case of the Poisson model, estimating
the probability of meeting the established accrual dead-
line has several practical implications. Although the meth-
ods have been presented in the context of a multi-center
clinical trial, they are valid in the planning of a single-
center clinical trial.
To facilitate implementation of the models in practice, a
spreadsheet template for the calculation of the condi-
tional model and SAS programs for the Poisson process
are posted on the first author's website http://peo
ple.musc.edu/~carterre/manuscripts. Each may be freely
downloaded and implemented with very little training.
The posted conditional model allows for individual sites
to enroll at site-specific rates as well as provides means to
quickly adjust model assumptions so that sensitivity anal-
yses can be performed. A more detailed discussion of the
Poisson method is available elsewhere [1]. In summary,
the conditional and Poisson accrual estimation methods
may be useful to researchers designing a complex, multi-
center clinical trial.
Expected accrual rate by month assuming an April 2005 start date Figure 1
Expected accrual rate by month assuming an April 2005 start date.Publish with BioMed Central    and   every 
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Conclusion
The accrual period of a clinical trial should be carefully
considered, and the allocation of sufficient time for partic-
ipant recruitment is a fundamental aspect of planning a
clinical trial. For most multi-center clinical trials, the con-
ditional approach should be implemented. Simulation
studies using the Poisson model are recommended if
there is uncertainty in the accrual rate or if the accrual rate
is expected to change over time.
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